NeurAxis Announces $5.0 Million Registered Direct Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 20 2025
0mins
Source: Globenewswire
NeurAxis Stock Offering Announcement: NeurAxis, Inc. has announced a registered direct offering of 1,538,461 shares of its common stock at $3.25 per share, expected to close around May 22, 2025, with gross proceeds estimated at $5 million for working capital and corporate purposes.
Company Overview and Future Plans: NeurAxis focuses on neuromodulation therapies for chronic conditions in children and adults, including its FDA-cleared IB-Stim™ therapy for IBS in adolescents, and is conducting further clinical trials for various health issues.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
